[{"address1": "7750 El Camino Real", "address2": "Suite 2A", "city": "Carlsbad", "state": "CA", "zip": "92009", "country": "United States", "phone": "858 704 4900", "website": "https://www.palisadebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn's disease. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. J. D. Finley", "age": 66, "title": "CEO, CFO & Director", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 813000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mitchell Lawrence Jones M.D., Ph.D.", "age": 47, "title": "COO & Chief Medical Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 581000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joerg  Heyer Ph.D.", "title": "Head of Translational Science & Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryker  Willie", "title": "Senior VP of Finance & Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.815, "open": 0.847, "dayLow": 0.7951, "dayHigh": 0.847, "regularMarketPreviousClose": 0.815, "regularMarketOpen": 0.847, "regularMarketDayLow": 0.7951, "regularMarketDayHigh": 0.847, "payoutRatio": 0.0, "beta": 1.41, "forwardPE": -0.08782895, "volume": 291869, "regularMarketVolume": 291869, "averageVolume": 2193538, "averageVolume10days": 10248860, "averageDailyVolume10Day": 10248860, "bid": 0.7781, "ask": 0.8524, "bidSize": 5, "askSize": 5, "marketCap": 4001515, "fiftyTwoWeekLow": 0.6, "fiftyTwoWeekHigh": 4.32, "fiftyDayAverage": 0.8114, "twoHundredDayAverage": 1.22745, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2215440, "profitMargins": 0.0, "floatShares": 8357885, "sharesOutstanding": 4795650, "sharesShort": 335788, "sharesShortPriorMonth": 949045, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0672, "heldPercentInsiders": 0.00241, "heldPercentInstitutions": 0.00813, "shortRatio": 0.34, "shortPercentOfFloat": 0.070300005, "impliedSharesOutstanding": 4995650, "bookValue": 0.545, "priceToBook": 1.4697248, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -11845000, "trailingEps": -3.64, "forwardEps": -9.12, "lastSplitFactor": "1:15", "lastSplitDate": 1712534400, "enterpriseToEbitda": -0.183, "52WeekChange": -0.7783934, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 0.801, "targetHighPrice": 14.0, "targetLowPrice": 2.0, "targetMeanPrice": 8.0, "targetMedianPrice": 8.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 5429000, "totalCashPerShare": 0.595, "ebitda": -12125000, "totalDebt": 338000, "quickRatio": 1.369, "currentRatio": 1.624, "debtToEquity": 12.901, "returnOnAssets": -0.77592003, "returnOnEquity": -1.8848, "freeCashflow": -6058500, "operatingCashflow": -9664000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PALI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755288000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.64, "epsForward": -9.12, "epsCurrentYear": -1.55, "priceEpsCurrentYear": -0.51677424, "fiftyDayAverageChange": -0.010399997, "fiftyDayAverageChangePercent": -0.012817349, "twoHundredDayAverageChange": -0.42645, "twoHundredDayAverageChangePercent": -0.3474276, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Seneca Biopharma, Inc.", "nameChangeDate": "2025-08-15", "averageAnalystRating": "1.3 - Strong Buy", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1755302058, "regularMarketTime": 1755288000, "exchange": "NCM", "messageBoardId": "finmb_244367385", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.71779, "regularMarketPrice": 0.801, "shortName": "Palisade Bio, Inc.", "longName": "Palisade Bio, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1175261400000, "postMarketChangePercent": -3.62047, "postMarketPrice": 0.772, "postMarketChange": -0.029, "regularMarketChange": -0.014, "regularMarketDayRange": "0.7951 - 0.847", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2193538, "fiftyTwoWeekLowChange": 0.20099998, "fiftyTwoWeekLowChangePercent": 0.33499995, "fiftyTwoWeekRange": "0.6 - 4.32", "fiftyTwoWeekHighChange": -3.519, "fiftyTwoWeekHighChangePercent": -0.8145833, "fiftyTwoWeekChangePercent": -77.83934, "dividendDate": 1563408000, "displayName": "Palisade Bio", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]